Compare MTB & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MTB | GEHC |
|---|---|---|
| Founded | 1856 | 1892 |
| Country | United States | United States |
| Employees | 21866 | N/A |
| Industry | Major Banks | Computer Software: Prepackaged Software |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.9B | 29.1B |
| IPO Year | N/A | 2022 |
| Metric | MTB | GEHC |
|---|---|---|
| Price | $231.02 | $65.16 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 17 | 13 |
| Target Price | ★ $228.59 | $88.38 |
| AVG Volume (30 Days) | 854.0K | ★ 4.4M |
| Earning Date | 04-15-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.78% | 0.24% |
| EPS Growth | N/A | ★ 4.84 |
| EPS | N/A | ★ 0.85 |
| Revenue | N/A | ★ $20,625,000,000.00 |
| Revenue This Year | $9.87 | $7.12 |
| Revenue Next Year | $3.66 | $4.45 |
| P/E Ratio | ★ $13.63 | $75.99 |
| Revenue Growth | N/A | ★ 4.84 |
| 52 Week Low | $174.76 | $58.75 |
| 52 Week High | $239.00 | $89.77 |
| Indicator | MTB | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 70.39 | 53.21 |
| Support Level | $211.90 | $60.80 |
| Resistance Level | $233.52 | $78.79 |
| Average True Range (ATR) | 3.84 | 1.60 |
| MACD | 1.69 | 0.46 |
| Stochastic Oscillator | 97.84 | 76.06 |
M&T Bank is a US regional bank with around $215 billion in assets as of the end of the first quarter of 2026. Headquartered in Buffalo, New York, the bank's footprint is mostly concentrated in New England and the US Mid-Atlantic. M&T Bank boasts a community banking approach, and boasts over 900 branches in 13 states and Washington, D.C. Apart from retail and commercial banking, M&T Bank also has wealth management operations through Wilmington Trust and a partnership with LPL Financial, and a corporate trust business.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).